Cargando…
Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells
BACKGROUND: The use of gene therapy to treat prostate cancer is hampered by the lack of effective nanocarriers that can selectively deliver therapeutic genes to cancer cells. To overcome this, we hypothesize that conjugating lactoferrin, a tumor-targeting ligand, and the diaminobutyric polypropyleni...
Autores principales: | Almowalad, Jamal, Laskar, Partha, Somani, Sukrut, Meewan, Jitkasem, Tate, Rothwelle J, Dufès, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968073/ https://www.ncbi.nlm.nih.gov/pubmed/35369035 http://dx.doi.org/10.2147/IJN.S347574 |
Ejemplares similares
-
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro
por: Almowalad, Jamal, et al.
Publicado: (2021) -
Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells
por: Maeyouf, Khadeejah, et al.
Publicado: (2023) -
Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells
por: Meewan, Jitkasem, et al.
Publicado: (2022) -
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
por: Altwaijry, Najla, et al.
Publicado: (2018) -
PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells
por: Somani, Sukrut, et al.
Publicado: (2018)